Nu Skin Enterprises (NYSE: NUS) reported Q1 EPS of $0.91, $0.19 better than the analyst estimate of $0.72. Revenue for the quarter came in at $677 million versus the consensus estimate of $635.4 million.

GUIDANCE:

Nu Skin Enterprises sees Q2 2021 EPS of $0.97-$1.07, versus the consensus of $1.03. Nu Skin Enterprises sees Q2 2021 revenue of $680-705 million, versus the consensus of $691.15 million.

Nu Skin Enterprises sees FY2021 EPS of $4.05-$4.30, versus the consensus of $3.99. Nu Skin Enterprises sees FY2021 revenue of $2.8-2.87 billion, versus the consensus of $2.78 billion.

For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.